Postow, M. A., Chasalow, S. D., Kuk, D., Panageas, K. S., Cheng, M. L., Yuan, J., & Wolchok, J. D. (2020). Absolute lymphocyte count as a prognostic biomarker for overall survival in patients with advanced melanoma treated with ipilimumab. Melanoma Res.
Citación estilo ChicagoPostow, Michael A., Scott D. Chasalow, Deborah Kuk, Katherine S. Panageas, Michael L. Cheng, Jianda Yuan, y Jedd D. Wolchok. "Absolute Lymphocyte Count As a Prognostic Biomarker for Overall Survival in Patients With Advanced Melanoma Treated With Ipilimumab." Melanoma Res 2020.
Cita MLAPostow, Michael A., et al. "Absolute Lymphocyte Count As a Prognostic Biomarker for Overall Survival in Patients With Advanced Melanoma Treated With Ipilimumab." Melanoma Res 2020.